Advances in Cancer Research
Academic Press
Published on 23. July 1985
354 pages
978-0-08-056226-1 (ISBN)
Description
Advances in Cancer Research
More details
Other editions
Additional editions
George Klein | Sidney Weinhouse
Advances in Cancer Research: v. 44
Book
07/1985
Academic Press
€59.52
Article exhausted; check different version
Persons
Content
- Front Cover
- Advances in Cancer Research, Volume 44
- Copyright Page
- Contents
- Contributors to Volume 44
- Chapter 1. Human Cancer-Associated Antigens: Present Status and Implications for Immunodiagnosis
- I. Introduction
- II. Approaches to the Identification of Human TAA
- III. Gangliosides as TAA
- IV. Heterogeneity in the Expression of Human TAA
- V. Immunodiagnosis of Cancer
- VI. Concluding Remarks
- References
- Chapter 2. Genetic Suppression of Tumor Formation
- I. Introduction
- II. Analysis by Cell Genetics: Methodology
- III. Analysis by Cell Genetics: Results
- IV. Analysis by DNA Transfer
- V. Concluding Remarks
- References
- Chapter 3. The Nude Mouse in Cancer Research
- I. Introduction
- II. Human Tumor Growth in Nude Mice
- III. Host and Tumor Properties Affecting Human Tumor Growth
- IV. Histopathological Characteristics of Human Tumor Growth in Nude Mice
- V. Stability of Human Tumor Growth and Tumor Functions Maintained in Nude Mice
- VI. Other Aspects af Human Tumor Growth
- VII. Tumor Growth in Nude Mice as an Aid to Diagnosis and Etiology
- VIII. Host Tissue Reaction to Human Tumor Transplants in Nude Mice
- IX. Nude Mouse-Grown Human Tumors as a Source for in Vitro Culture
- X. Transplantation of Malignant Nonhuman Tumor Cells to Nude Mice
- XI. Human Premalignant or Benign Tumors
- XII. Xenotransplantation of Nonmalignant, Nonhuman Tissues
- XIII. Growth of Normal Human Tissues in Nude Mice
- XIV. Carcinogenesis
- XV. Cell Hybrids and Monoclonal Antibodies
- XVI. Metastasis
- XVII. Stroma Transformation
- XVIII. Spontaneous Tumors
- XIX. Additional Immunodeficiencies
- XX. Additional Conditions That Can Modify Tumor Growth in Nudes
- XXI. Chemotherapy
- XXII. Rrdiotherapy
- XXIII. Endocrine Therapy
- XXIV. Immunotherapy
- XXV. Hyperthermia
- XXVI. Conclusion
- References
- Chapter 4. Seroepidemiological Studies on Nasopharyngeal Carcinoma in China
- I . Introduction
- II. Distribution and Spectra of EB Virus Antibodies in NPC Patients and Normal Individuals
- III. Serological Mass Surveys and Prospective Studies on NPC
- IV. IgA/EA Antibody as a Specific Marker for NPC
- V. Relationship between IgA/VCA Antiboby and EB Virus Markers (DNA and EBNA)
- VI . Relationship between EB Virus IgA/VCA Antiboby and Clinical Changes in Nasopharynx
- VII. Relationship between EB Virus lgA/VCA Anitiboby and Histolgical Changes in Nasopharynx
- VIII. Conclusion
- References
- Chapter 5. Plasminogen Activators, Tissue Degradation, and Cancer
- I. Introduction
- II. Biochemistry of Plasminogen Activators
- III. Assays and Detection Methods fbr Plasminogen Activators
- IV. Occurrence and Function of Plasminogen Activators in Nonneoplastic Conditions
- V. Occurrence and Function of Plasminogen Activators in Neoplasia
- VI. Subcellular Localization of Plasminogen Activators
- VII. Regulation of Plasminogen Activator Activity
- VIII. Conclusions and Perspectives
- References
- Chapter 6. The Mechanism of Action of mAMSA
- I. Introduction
- II. The AMSA Series of Antitumor Drugs
- III. Biological Effects of AMSA Drugs
- IV. Cellular Targets of mAMSA Action
- V. Other DNA-Intercalating Antitumor Drugs
- VI. Alternative Cellular Targets
- VII. The Question of Cytotoxicity
- VIII. Addendum
- References
- Chapter 7. Retroviruses as Chromosomal Genes in the Mouse
- I. Introduction
- II. The Classification and Genomic Structure of Mouse Retroviruses
- III. Germline Retroviral Genes
- IV. Germline and Somatic Mutations Associated with Retrovirus Integration
- V. Tumor Induction by Retrovirus Integration
- VI. Conclusions
- References
- Index
- Contents of Recent Volumes
